SL
MDGL icon

Siren LLC’s Madrigal Pharmaceuticals MDGL Stock Holding History

Siren LLC’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-125,942
Closed -$38.9M – 130
2024
Q4 		$38.9M Buy
+125,942
New +$35.4M 1.72% 16

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC's MDGL Position: Q1 2025 in Review

Siren LLC sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2025, closing a stake of 125,942 shares — an estimated $38.9M sold.

Siren LLC first reported a position in MDGL in Q4 2024 and held it in 1 quarter. The position peaked at $38.9M in Q4 2024. 321 funds tracked by Wall St. Rank hold MDGL as of Q1 2025.

  • Siren LLC reported no remaining Madrigal Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Siren LLC sold 125,942 Madrigal Pharmaceuticals shares in Q1 2025, an estimated $38.9M.
  • Siren LLC first reported a position in Madrigal Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Siren LLC's Madrigal Pharmaceuticals position peaked at $38.9M in Q4 2024.
  • 321 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2025.

Based on Siren LLC's 13F filing for Q1 2025, filed 14 May 2025.